Outside the pandemic, “investigational” remains payer code for denying reimbursement. In the case of treatment for chronic conditions, even FDA-approved digital-health and connected devices languish on waitlists for formulary inclusion.
Healthcare has to assume responsibility for its failure to address color based care in the industry. Gender and racial bias still permeate American Healthcare.
